CSL provides COVID-19 update and reaffirms guidance

The CSL Limited (ASX:CSL) share price will be on watch on Thursday after releasing a COVID-19 update and reaffirming its guidance…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price will be on watch on the S&P/ASX 200 Index (ASX: XJO) on Thursday.

This follows the release of a COVID-19 update by the biotherapeutics giant.

What did CSL announce?

This morning CSL provided investors with a comprehensive update on how the COVID-19 pandemic is impacting its business.

According to the release, plasma collections are expected to be impacted by the pandemic.

However, the company is optimistic it will be able to mitigate this through a number of initiatives. These include collection centres being designated essential critical infrastructure, safe passage letters provided to staff and donors, and FDA initiatives to release plasma earlier in the cycle.

In addition to this, it notes that it has the potential to accelerate plasma collection post crisis and expects an increase in new donors due to the economic downturn. If this eventuates, it should limit any impact to its sales in FY 2021. 

Commercial update.

CSL also provided an update on its commercial activities. It reminded investors that the majority of its products are life saving or life extending and not discretionary.

As a result, current demand is consistent with expectations. Furthermore, requests for IVIG are elevated and influenza vaccine demand is strong.

Positively, there are currently no items out of stock and no interruptions to its supply chain.

One small negative is that there are modest delays expected in capital projects and clinical trials. However, management is aiming to accelerate activity post crisis to ensure there are no material changes to its original plan.


CSL has become one of only a handful of companies that have been able to maintain their guidance in FY 2020. Management has reaffirmed its FY 2020 profit guidance of ~US$2,110 million to US$2,170 million in constant currency.

The company also notes that it is in a strong capital position with an estimated US$1.1 billion of available liquidity.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three analysts look at tech options on a wall screen
Share Market News

Here's how the ASX 200 market sectors stacked up this week

ASX tech shares are on fire, leading the 11 market sectors for a third consecutive week.

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Market News

Here are the top 10 ASX 200 shares today

The ASX 200 clocked a few new all-time highs this Friday.

Read more »

A young couple stands next to a real estate agent in an empty apartment they are inspecting
Share Market News

How ASX shares vs. property performed in February

We reveal the property price growth for each city and regional market and the top 5 risers of the ASX…

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Ampol, Calix, Collins Foods, and Propel shares are tumbling today

These ASX shares are ending the week in the red. But why?

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Technology Shares

The Nasdaq just hit a fresh all-time high. What could it mean for Aussie investors?

With the Nasdaq at fresh highs, ASX tech shares are reaping the benefits.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Core Lithium, Life360, Syrah, and Xero shares are jumping today

These ASX shares are ending the week on a high. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Market News

Boom! ASX 200 rocketing into new all-time highs on Friday

The ASX 200 is setting new records on Friday.

Read more »